NCT02559141View on ClinicalTrials.gov

Non-invasive Early Goal Directed Therapy in Colorectal Surgery: a Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Perioperative/Postoperative ComplicationsC.Surgical Procedure; Digestive System
Interventions
DRUG

Dobutamine

If PPV ≤10%, volume substitution of 500 ml of crystalloids and/or colloids as long as CI was ≥2.5 l/min/m². Maintenance of CI ≥2.5 l/min/m² and MAP ≥65 mmHg was achieved by using dobutamine (10 µg/kg/min) and norepinephrine (0.03 µg/kg/min).

Trial Locations (1)

24105

Ole Broch, Kiel

All Listed Sponsors
lead

University Hospital Schleswig-Holstein

OTHER

NCT02559141 - Non-invasive Early Goal Directed Therapy in Colorectal Surgery: a Feasibility Study | Biotech Hunter | Biotech Hunter